Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater…
-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater…
WALL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative…
Revenue up 34% year-over-year to $49.9M, GAAP operating income of $0.9 million and Adjusted EBITDA…
Zai Lab obtains exclusive rights to develop and commercialize KarXT in Greater China Karuna to…
-- Broad Product Pipeline Expands Both Vertically and Horizontally with Three New Potential First-in-Class or…
12.4% Year-Over-Year Revenue Growth 56.4% Year-Over-Year Subscription Revenue Growth $16.5 million in Net Cash Provided…
DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), the Colorado-based direct-to-consumer (D2C)…
Business Highlights Total revenues of $29.6 million for the third quarter of 2021, up 28%…
Total Revenue Increases 20% Year-over-YearEnterprise Sales Revenue Increases 37% Year-over-Year SAN MATEO, Calif., Nov. 09,…
DENVER--(BUSINESS WIRE)--Newmont (NYSE: NEM, TSX: NGT) (Newmont or the Company) has agreed to sell its…